st 1435 has been researched along with ethinyl estradiol in 16 studies
| Studies (st 1435) | Trials (st 1435) | Recent Studies (post-2010) (st 1435) | Studies (ethinyl estradiol) | Trials (ethinyl estradiol) | Recent Studies (post-2010) (ethinyl estradiol) |
|---|---|---|---|---|---|
| 97 | 31 | 33 | 9,070 | 1,566 | 1,732 |
| Protein | Taxonomy | st 1435 (IC50) | ethinyl estradiol (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 2.2 | |
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Estrogen receptor | Homo sapiens (human) | 0.0035 | |
| Glucocorticoid receptor | Homo sapiens (human) | 1.71 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 1.71 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 0.959 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 5.678 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 4.8812 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 1.71 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 1.71 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.959 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 1.71 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.054 | |
| Sulfotransferase 1A1 | Homo sapiens (human) | 0.02 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.559 | |
| Aldehyde oxidase | Homo sapiens (human) | 0.57 | |
| Nuclear receptor subfamily 1 group I member 3 | Homo sapiens (human) | 3 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.0129 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Sanchez, F; Brache, V; Faundes, A; Jackanicz, T | 1 |
| Haukkamaa, M; Heikinheimo, O; Laurikka-Routti, M | 1 |
| Alvarez, F; Brache, V; Elomaa, K; Fraser, IS; Lacarra, M; Lähteenmäki, P; Mishell, DR; Nash, HA; Weisberg, E | 1 |
| Jackanicz, T; Kumar, N; Sitruk-Ware, R; Small, M; Sundaram, K; Tsong, YY | 1 |
| Alvarez, F; Apter, D; Brache, V; Fraser, IS; Gale, J; Massai, R; Mishell, DR; Sivin, I; Tsong, YY; Weisberg, E | 2 |
| Alvarez, F; Brache, V; Cochon, L; Croxatto, HB; Faundes, A; Forcelledo, ML; Massai, R; Pavez, M; Salvatierra, AM | 1 |
| Burggraaf, J; de Kam, ML; Kluft, C; Meijer, P; Ménard, J; Rad, M; Sitruk-Ware, RL; Sivin, I | 1 |
| Burggraaf, J; de Kam, ML; Kluft, C; Menard, J; Rad, M; Sitruk-Ware, RL; Sivin, I; Tokay, BA | 1 |
| Burggraaf, J; Cohen, AF; de Kam, ML; Kluft, C; Rad, M | 1 |
| Burggraaf, J; Cohen, AF; de Kam, ML; Kluft, C; Rad, M; Sitruk-Ware, RL | 1 |
| Cooney, M; Hewett, PC; Hoskin, E; Mensch, BS; Merkatz, RB; Plagianos, M | 1 |
| Archer, DF; Blithe, D; Conard, J; Creasy, GW; Merkatz, RB; Plagianos, M; Roberts, K; Sitruk-Ware, R; Thomas, MA | 1 |
| Alami, M; Creasy, G; Han, L; Hoskin, E; Kumar, N; Merkatz, R; Plagianos, M; Roberts, K; Simmons, KB; Variano, B | 1 |
| Merkatz, RB; Plagianos, M; Stifani, BM; Vieira, CS | 1 |
| Blithe, DL; Blue, SW; Edelman, AB; Erikson, DW; Fecteau, KM; Jensen, JT | 1 |
1 review(s) available for st 1435 and ethinyl estradiol
| Article | Year |
|---|---|
Nestorone: clinical applications for contraception and HRT.
Topics: Animals; Contraception; Contraceptive Agents, Female; Ethinyl Estradiol; Female; Hormone Replacement Therapy; Humans; Models, Chemical; Norprogesterones; Ovulation; Progesterone; Protein Binding; Rats; Time Factors | 2003 |
11 trial(s) available for st 1435 and ethinyl estradiol
| Article | Year |
|---|---|
Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles.
Topics: Administration, Intravaginal; Adolescent; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Estrogens; Ethinyl Estradiol; Evaluation Studies as Topic; Female; Gonadal Steroid Hormones; Humans; Levonorgestrel; Lipoproteins; Menstrual Cycle; Menstruation; Norprogesterones; Progesterone; Radioimmunoassay | 1992 |
Vaginal epithelial surface appearances in women using vaginal rings for contraception.
Topics: Adolescent; Adult; Colposcopy; Contraceptive Agents, Female; Contraceptive Devices, Female; Edema; Epithelium; Erythema; Ethinyl Estradiol; Female; Humans; Norethindrone; Norprogesterones; Progesterone Congeners; Ulcer; Vagina | 2000 |
Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone progestogen-ethinyl estradiol contraceptive vaginal ring on a bleeding-signaled regimen.
Topics: Contraceptive Agents, Female; Contraceptive Devices, Female; Ethinyl Estradiol; Female; Humans; Menstruation; Norprogesterones; Ovarian Follicle; Ovulation Inhibition; Pregnancy; Progesterone | 2005 |
Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen.
Topics: Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Ethinyl Estradiol; Female; Humans; Menstruation; Norprogesterones; Pregnancy; Uterine Hemorrhage | 2005 |
Feasibility study of Nestorone-ethinylestradiol vaginal contraceptive ring for emergency contraception.
Topics: Administration, Intravaginal; Adult; Contraception, Postcoital; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstrual Cycle; Norprogesterones; Ovarian Follicle; Ovulation; Progesterone; Ultrasonography; Uterine Hemorrhage | 2006 |
Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables.
Topics: Activated Protein C Resistance; Adolescent; Adult; Blood Coagulation Factors; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Fibrinolysis; Humans; Immunoradiometric Assay; Norprogesterones; Plasminogen; Protein C; Sex Hormone-Binding Globulin | 2006 |
Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
Topics: Adolescent; Adult; Blood Proteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norprogesterones; Sex Hormone-Binding Globulin; Triglycerides | 2007 |
Increased impact of a contraceptive vaginal ring with ethinyl estradiol and nestorone on C-reactive protein.
Topics: Adolescent; Adult; C-Reactive Protein; Contraceptive Devices, Female; Ethinyl Estradiol; Female; Humans; Norprogesterones; Young Adult | 2012 |
Impact on hepatic estrogen-sensitive proteins by a 1-year contraceptive vaginal ring delivering Nestorone® and ethinyl estradiol.
Topics: Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estrogens; Ethinyl Estradiol; Factor VIII; Female; Fibrinogen; Humans; Norprogesterones; Protein S; Sex Hormone-Binding Globulin | 2016 |
Effects of concurrent vaginal miconazole treatment on the absorption and exposure of Nestorone® (segesterone acetate) and ethinyl estradiol delivered from a contraceptive vaginal ring: a randomized, crossover drug-drug interaction study.
Topics: Administration, Intravaginal; Adolescent; Adult; Antifungal Agents; Area Under Curve; Candidiasis, Vulvovaginal; Contraceptive Agents, Female; Contraceptive Devices, Female; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Miconazole; Norprogesterones; Vaginal Absorption; Young Adult | 2018 |
Factors associated with nonadherence to instructions for using the Nestorone®/ethinyl estradiol contraceptive vaginal ring.
Topics: Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Ethinyl Estradiol; Factor Analysis, Statistical; Female; Humans; Internationality; Logistic Models; Multivariate Analysis; Norprogesterones; Patient Compliance; Young Adult | 2018 |
4 other study(ies) available for st 1435 and ethinyl estradiol
| Article | Year |
|---|---|
A contraceptive vaginal ring releasing ethinyl estradiol and the progestin ST-1435: bleeding control, serum steroid concentrations, serum lipids and serum chemistry.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Devices, Female; Estradiol; Ethinyl Estradiol; Female; Humans; Liver; Menstruation; Minerals; Norpregnenes; Norprogesterones; Progesterone; Triglycerides | 1990 |
Discriminant analysis of the metabolic effects of a new combined contraceptive vaginal ring containing Nestorone/EE vs. a second-generation oral contraceptive containing levonorgestrel/EE.
Topics: Angiotensinogen; Blood Coagulation Factors; Blood Pressure; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Discriminant Analysis; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norprogesterones; Risk; Sex Hormone-Binding Globulin; Thrombosis; Triglycerides | 2012 |
Acceptability of the Nestorone®/ethinyl estradiol contraceptive vaginal ring: development of a model; implications for introduction.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Ethinyl Estradiol; Factor Analysis, Statistical; Female; Humans; Models, Theoretical; Norprogesterones; Patient Acceptance of Health Care; Young Adult | 2014 |
Simultaneous assay of segesterone acetate (Nestorone®), estradiol, progesterone, and estrone in human serum by LC-MS/MS.
Topics: Chromatography, Liquid; Drug Combinations; Estradiol; Estrone; Ethinyl Estradiol; Female; Humans; Norprogesterones; Pregnenediones; Progesterone; Tandem Mass Spectrometry | 2020 |